DavidBSolitMD

PubMed

• Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma.
  Michelangelo Marasco, Dinesh Kumar, Tessa Seale, Santiago Garcia Borrego, Esther Kaplun
  Cell Reports. Medicine. 2024-11-19
• Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma.
  Kwanghee Kim, Syed M Alam, Fengshen Kuo, Ziyu Chen, Wesley Yip
  European Urology. 2024-11-15
• 1 citations
  Automated real-world data integration improves cancer outcome prediction.
  Justin Jee, Christopher Fong, Karl Pichotta, Thinh Ngoc Tran, Anisha Luthra
  Nature. 2024-11-06

Journal Articles

• Article Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer  
  Sarat Chandarlapaty, Alison M Schram, David M Hyman, David B Solit, ScienceDirect
• Neratinib Is Effective in Breast Tumors Bearing Both Amplification and Mutation of ERBB2 (HER2)  
  José Baselga, Kyriakos P. Papadopoulos, Sarat Chandarlapaty, David B. Solit, Science Magazine
• Genome Doubling Shapes the Evolution and Prognosis of Advanced Cancers  
  Alison M Schram, Jose Baselga, Mark E Robson, David B Solit, Zsofia K Stadler, Nature

Abstracts/Posters

• Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase
  David B. Solit, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Drugging the Undruggable 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Activating Mutations in CSF1R and Additional Receptor Tyrosine Kinases in Sporadic and Familial Histiocytic Neoplasms 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Role of cfDNA in the Treatment of Patients With Advanced Cancer 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018